TGF-beta 3產(chǎn)品信息
英文名稱:Transforming growth factor beta 3
中文名稱:轉(zhuǎn)化生長因子β3
靶點別稱:TGFB3,ARVD,TGF-beta3
物種:Human
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
無菌(Sterility)
The sterility testing was performed by membrane filtration method.
支原體(Mycoplasma)
Negative.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM HAC, pH2.8 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
TGF-beta 3分子背景
轉(zhuǎn)化生長因子β3(TGFB3)也稱為TGF-β3,是轉(zhuǎn)化生長因子-β超家族細(xì)胞因子的多肽成員。它是一種分泌的蛋白質(zhì),執(zhí)行許多細(xì)胞功能,包括調(diào)節(jié)胚胎發(fā)生和細(xì)胞分化,是次級腭發(fā)育等各種過程所必需的。TGF-β3與TGF-β1和-β2相似,充當(dāng)細(xì)胞開關(guān),調(diào)節(jié)免疫功能、細(xì)胞增殖和上皮間質(zhì)轉(zhuǎn)化。整合素從LAP釋放TGF-β-3:整合素結(jié)合導(dǎo)致LAP鏈扭曲,隨后釋放活性TGF-β-3。一旦LAP釋放后被激活,TGF-β-3通過與TGF-β受體(TGFBR1和TGFBR2)結(jié)合起作用,TGF-β受體負(fù)責(zé)轉(zhuǎn)導(dǎo)信號。
關(guān)鍵字: TGF-beta 3;TGFB3;轉(zhuǎn)化生長因子β3;TGF-β3;TGFB3蛋白;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。